Nicholas Investment Partners, LP Gossamer Bio, Inc. Transaction History

Nicholas Investment Partners, LP

  • $900 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$7.21 - $14.88 $3.38 Million - $6.98 Million
469,317 New
469,317 $5.62 Million
Q3 2019

Nov 13, 2019
SELL
$16.02 - $22.47 $2.3 Million - $3.22 Million
-143,342 Closed
0 $0
Q2 2019

Aug 09, 2019
SELL
$16.12 - $22.89 $9,784 - $13,894
-607 Reduced 0.42%
143,342 $3.18 Million
Q1 2019

May 15, 2019
BUY
$17.58 - $23.97 $2.53 Million - $3.45 Million
143,949 New
143,949 $3.12 Million

Others Institutions Holding GOSS

# of Institutions
108
Shares Held
167M
Call Options Held
430K
Put Options Held
519K
View Full List

About Gossamer Bio, Inc.

GOSS Quotes by TradingView
  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $81.7M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email